Serum thyrotropin (TSH) concentrations were measured serially in 14 heart-transplant recipients (group 1) and 21 patients undergoing coronary artery bypass surgery (group 2), all without thyroid disease, and randomly in 158 patients hospitalized for various other nonthyroidal illnesses, including 144 judged euthyroid (group 3), six with increased FT4 and (or) T3 (group 4), and eight classified hypothyroid by conventional tests. The serial measurements indicated profound fluctuations. In group 1, TSH was subnormal in 21% of studies and increased in 10%. In group 2, corresponding abnormalities were found in 7% and 13%, respectively. Transiently low or high TSH tended to be associated with normal free thyroxiri (FT4), prolonged subnormal TSH (>1 week) with subnormal FT4. By contrast, subnormal TSH plus elevated FT4, or high TSH plus low FT4, were not encountered, making it unlikely that they occur by chance in severely ill patients who are not also hyper-or hypothyroid. In group 3, a suppressed TSH (plus borderline high FT4, T3/FT3) identified four cases of subclinical hyperthyroidism; however, another 11% of patients had subnormal and 10% had abovenormal TSH, paired with normal FT4 and no evidence of thyroid disease. In group 4, suppressed TSH confirmed hyperthyroidism in five of six patients, and all in group 5 had increased TSH. We conclude that, in the hospital setting, sensitive TSH measurement can help to detect or confirm mild hyperthyroidism, but the positive predictive value of TSH alone may be as low as 35%.
Serum thyrotropin (TSH) concentrations were measured serially in 14 heart-transplant recipients (group 1) and 21 patients undergoing coronary artery bypass surgery (group 2), all without thyroid disease, and randomly in 158 patients hospitalized for various other nonthyroidal illnesses, including 144 judged euthyroid (group 3), six with increased FT4 and (or) T3 (group 4), and eight classified hypothyroid by conventional tests. The serial measurements indicated profound fluctuations. In group 1, TSH was subnormal in 21% of studies and increased in 10%. In group 2, corresponding abnormalities were found in 7% and 13%, respectively. Transiently low or high TSH tended to be associated with normal free thyroxiri (FT4), prolonged subnormal TSH (>1 week) with subnormal FT4. By contrast, subnormal TSH plus elevated FT4, or high TSH plus low FT4, were not encountered, making it unlikely that they occur by chance in severely ill patients who are not also hyper-or hypothyroid. In group 3, a suppressed TSH (plus borderline high FT4, T3/FT3) identified four cases of subclinical hyperthyroidism; however, another 11% of patients had subnormal and 10% had abovenormal TSH, paired with normal FT4 and no evidence of thyroid disease. In group 4, suppressed TSH confirmed hyperthyroidism in five of six patients, and all in group 5 had increased TSH. We conclude that, in the hospital setting, sensitive TSH measurement can help to detect or confirm mild hyperthyroidism, but the positive predictive value of TSH alone may be as low as 35%.
In outpatients,
it is now fairly well established that the new "sensitive" These data raise the question as to how reliable sensitive TSH measurements are in hospitalized patients with severe NTI. Surveys have shown that many hospitalized patients undergo evaluation of thyroid function, which underscores the clinical relevance of such a question. For example, in our own laboratory, 32% of all thyroid tests requested are for hospitalized patients.
The aim of the present study was several fold: (a) to investigate further the extent to which serum TSH is affected by major surgery and (or) severe systemic illness; (b) to assess the clinical utility of sensitive TSH measurements in the hospital setting, particularly in the diagnosis of mild hyperthyroidism;
(c) to look at the relationship between FF4 and TSH concentrations in serum during serious illness; and (d) to try to establish some guidelines for the interpretation of disparate results for TSH and FF4.
Subjects and Methods
In the first part of this study we followed serum TSH prospectively in two groups of patients with heart disease who underwent major cardiac surgery: Group 1, 14 hearttransplant recipients (11 male, three female; age 43 ± 9 y) and group 2, 21 patients who underwent coronary artery bypass graft surgery or cardiac valve replacement (17 male, four female; age 57 ± 9 y). None of these patients had a history of thyroid dysfunction or had received treatment with thyroid or antithyroid medications. There was no thyromegaly or any clinical features that might have suggested thyroid disease. Blood specimens for serial hormone measurements were obtained on the day before and at intervals after surgery. Patients in group 1 were tested typically twice in the first postoperative week and then once per week. Patients in group 2 were tested daily the first week and twice in the second week.
In the second part of this investigation, we performed sensitive TSH measurements retrospectively on consecutive hospitalized patients for whom routine thyroid-function tests had been ordered. After reviewing the medical charts, the following patients were excluded from the study, to facilitate the interpretation of results: (a) patients who had a prior record of thyroid disease and (or) had been on any Mean pre-surgery FF4, total T4, and T3 concentrations in both groups were similar to those in healthy controls. Postoperatively, a large number of patients had subnormal ____________________ total T4 and (or) total T3 ( the rest suffered from a wide variety of other NTI. None of them was overtly hypo-or hyperthyroid.
Based on the results of routine free thyroxin (FF4), total 3,3',5-triiodothyromne (T3), and TSH measurements by conventional RIA, the selected patients were subdivided into three groups: Group 3, 144 patients classified clinically and biochemically as probably euthyroid. The vast majority of them had FF4 and TSH concentrations (by RIA) within normal limits, as will be described in detail below, but many had subnormal values for total thyroxm (T4) and (or) subnormal values for T3 (Table 1 below). Group 4, six patients who had an abnormally high value for FF4 or T3 and, thus, by conventional biochemical criteria were suspected of being mildly hyperthyroid, although there was little or no clinical evidence to support it. Group 5, eight patients who were biochemically hypothyroid on the basis of either a subnormal FF4 plus increased TSH of>10, or only an increased TSH of>20 milli mt.units/L. In groups 3-5 we used for the sensitive TSH measurement one specimen selected from each patient without conscious bias, as submitted for the routine thyroid evaluation.
In groups 1 and 2, TSH was measured by a two-step inununoradiometric assay from Hybritech Inc. (normal range 0.4-3.7 milli-int. unitWL) (4) and most of the results were confirmed by an enzyinoimmunometric assay from Abbott Laboratories (normal range 0.4-6.2 milli-int. units/L) (16). There was an excellent correlation between TSH results by the two assays, and in groups 3-5 only the latter assay was used. The performance characteristics for both the Hybritech assay (4) and the Abbott assay (1) have been described previously.
All values of <0.4 milli-int. unitlL stated here refer to the Abbott assay.
Other thyroid-function tests were performed as described previously (4) . Free T3 (FF3) was measured in all patients with subnormal TSH with a kit for FF3 ("Coat-A-Count,"
Diagnostics Product
Corp., normal range 13-36 ng/L), which we found to be least affected by variations in albumin concentrations when compared with other commercial methods.
Statistical analysis: Preoperative results were compared to controls by unpaired Student's t-test. In the case of TSH results, log TSH was used to fulfil the requirement of a normal distribution. Postoperative results were compared to the corresponding preoperative values by the paired t-test.
All P values refer to the area in two tails.
Results

Sequential Sensitive TSH Measurements in Patients Undergoing Cardiac Transplantation or Coronary Artery Bypass Graft Surgery (Groups 1 and 2, Figures 1A, 1B, and 2)
At the outset, all patients in group 2 had values for serum TSH within normal limits, and the mean TSH concentration was similar to that in healthy controls. In group 1, the presurgery mean TSH was significantly higher than in controls. (Five patients had a slightly increased TSH of 6.2-12, one had a TSH of 18 milli-int. units/L.)
Postoperatively, serum TSH fell sharply in both groups when compared to preoperative values. In group 1 significantly lower TSH concentrations were found at four intervals of sampling (days 4-7, 8-14, 15-21, and 21-28) with the nadir between days 8-14. In group 2, with daily sampling, the decline in TSH was statistically significant on days 1 and 2, and the nadir was seen already on the second day.
Two heart-transplant recipients who started out with a somewhat increased TSH ( Figure 1B ) even had intermittently subnormal TSH after surgery.
In one additional patient, with a clearly abnormal basal TSH of 30 milli-int.
units/L and a history of head and neck irradiation (excluded from statistical analysis and graphs), the TSH concentration declined after surgery to concentrations well within the normal reference interval (<3.2 milli-int. unitsfL), thus masking a thyroid insufficiency. After the initial postoperative decline, serum TSH tended to increase again as the patients' clinical status improved, but continued to vary strongly in individual patients (Figures 1 and 3) . The majority of the patients had typically only transiently subnormal TSH concentrations, but there were three patients in whom TSH remained subnormal for a prolonged period (longer than one week), while their clinical course worsened. All three (two in group 1, one in group 2) died subsequently. At discharge, mean TSH was lower than initially in group 1, and similar to controls in both groups.
Overall, in group 1, 43% of the patients had a subnormal TSH value at least once after surgery and, conversely, 21% had a mildly increased TSH. In group 2, the corresponding percentages were 24% and 43%, respectively. In terms of all TSH studies, 21% were low and 10% were high in group 1, and 7% were low and 13% were high in group 2. The magnitude of the postoperative intraindividual variations was such that TSH frequently exceeded the normal range on the low as well as on the high side (Figures 1 and 3) . #{149}. -. The trianglesincate preoperativehormoneconcentrations, the lines the range of postoperative values, the shaded areas the normalreferenceintervals statistical significance (P <0.02), and temporally coincided with the nadir of TSH. Also, the percentage change in serum FF4 for group 1 was generally less than 25%, while that of TSH was greater than 50% (Figure 4 ). The vast majority of patients in both groups had FF4 values continuously within normal limits throughout the period of observation. We found only two patients (14%) in group 1 and one (5%) in group 2 in whom FF4 became clearly subnormal, and one borderline case. All three patients with subnormal FF4 values had a subnormal TSH value for more than one week and died subsequently.
On the other hand, one patient in group 1 had consistently high FF4 ( Figure IB) and two in group 2 had temporarily increased FF4 (probably drug effects), while their TSH value was within the normal reference interval.
It is noteworthy that, despite the prevalence of abnormal TSH concentrations, none of the patients had, at any time, either a subnormal TSH and concomitantly increased FF4 (typical of hyperthyroidism), or a high TSH associated with a low FF4 (characteristic of hypothyroidism). Moreover, from the percentages of abnormal data we estimated a probability of only 0.002-0.015% that a subnormal TSH and an abnormally high FF4, both due to NTI, would coincidentally be associated in a sick euthyroid patient.
TSH Concentrations in a Representative Cross-Section of Hospitalized Patients with Miscellaneous NTI (Groups 3-5, Figures 5 and 6)
In group 5, all eight patients characterized as hypothyroid by conventional thyroid-function tests also had abnormally high TSH values by the sensitive assays. In group 4, patients suspected of being "subclinically hyperthyroid" because they had increased FF4 and (or) increased total T3 (FF4, 24 to >50 ngfL; T3, 2.5 to 3.35 pg/L), we found a completely suppressed (undetectable) TSH in four, and a subnormal TSH (0.16 milli-int. unitfL) in one patient. The sixth patient had a normal TSH of 1.4 milli-int. units/L (FF4, 25 ng/L).
In group 3, patients judged to be "euthyroid" on the basis of conventional tests, we observed a striking shift of TSH concentrations to lower values, when compared with healthy individuals ( Figure 5 ) and a total of 23 (15%) patients had subnormal TSH. Two of the latter patients had an undetectable TSH together with a borderline-high FF4 that was within the upper five percentile of FF4 results for the group (19 and 22 ng/L). Two others were found to have an increased or borderline-high FF3 (36 and 38, normal 13-36 ng/L) upon further testing. However, aside from these four cases-i.e., in the majority of cases-the subnormal TSH was found to be associated with normal FF4 concentrations, corresponding to the middle or lower end of the normal range, and low to normal totallfree T3, and there were no other biochemical (thyroid antibody tests) or clinical criteria to support a diagnosis of hyperthyroidism. Conversely, the sensitive TSH assay produced slightly above-normal results in 14 (10%) of patients in group 3, all of whom had a normal value for FF4, and only four of them had a slightly increased TSH value by our conventional RIA (10-25 milli-int. unitsfL). Two (1%) of the most gravely ill patients had a subnormal FF4 and a subnormal TSH value.
CONTROL
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Overall, the pattern of TSH and FF4 concentrations obtained by random measurements in group 3 was similar to that from serial measurements in groups 1 and 2 ( Figure  6 ). For example, the proportion of abnormal TSH results in patients with normal FF4 was similar and the subnormal TSH concentrations associated with normal FF4 were, in general, still measurable, rather than suppressed to undetectable values (0.05-0.4 milli-int. unitfL by the Abbott assay). Undetectable TSH was encountered only in 3% of studies in group 1, 4% in group 2, and 1% of patients in group 3 (exclusive of the four found to be borderline hyperthyroid).
Discussion
Our observations further underscore the fact that pituitary TSH secretion can be profoundly affected by major surgery and (or) severe systemic illness.
Judging from our serial measurements, however, it seems unlikely that a subnormal TSH plus supranormal FF4 or a supranormal TSH plus subnormal FF4 are found in a patient with NTI unless that patient is also hyper-or hypothyroid, respectively. Rather, it appears that inverse abnormalities in both TSH and FT4 are indicative of thyroid dysfunction and that their interpretation in hospitalized patients is virtually the same as in outpatients.
Consequently, we interpreted the finding of a subnormal TSH value in five of six patients with abnormally high thyroid hormones (group 4) as a confirmation of hyperthyroidism, and the finding of a subnormal TSH in four other patients with borderline high FF4 and FF3 (group 3) as a sign of subclinical hyperthyroidism.
Clinically, sensitive TSH measurements may, e.g., be useful in hospitalized patients with unexplained tachycardia who routinely undergo evaluation of thyroid function to establish, or rule out, mild hyperthyroidism. During this study, one patient with atrial fibrillation and a high FF4 value of 33 ng/L was found to have a subnormal TSH of 0.01 milli-int. unitlL, which provided further evidence for subclinical thyroid disease.
On the other hand, our data also indicate that "sensitive" TSH assays readily detect minor, temporary abnormalities of serum TSH in sick patients and, thus, generate a significant number of abnormal (low or high) results, while FT4 tends to remain normal, consistent with the longer biological half-life of T4 in plasma and previous observations from single FF4 measurements during NTI (17-19) . The disparate TSH and FF4 results are difficult to interpret.
In (untreated) outpatients, a suppressed TSH paired with a normal FF4 is virtually synonymous with early stages of hyperthyroidism (3) (4) (5) , while an increased TSH plus normal FF4 is characteristic of compensated hypothyroidism. By contrast, these sets of results, per se, in patients with NTI are inconclusive.
They can either reflect a mild intrinsic thyroid disorder, or they can be entirely manifestations of the systemic illness (temporary fall in pituitary TSH secretion and rebound phenomenon, 13, 14), or they can be combinations thereof. However, we encountered these abnormalities relatively frequently in the serial studies, where thyroid disease was ruled out to the extent possible, and so it appears that in severely ill patients with no history of thyroid disease these results are more often than not caused by the NTI. Therefore, as described in Table 2 , an abnormal TSH plus a normal FF4, or the reverse, has to be interpreted differently in severely ill patients than is customary in outpatients.
Estimates for the diagnostic performance of sensitive TSH measurements in hospital settings like ours are shown in Table 3 . Estimates are based on the data obtained for groups 3-5. We assumed that abnormal TSH results were truepositive results for intrinsic thyroid disease when they were coupled with complementary thyroid hormone abnormalities (subnormal FF4, in the case of hypothyroidism, and elevated FF41F31FF3, in the case of hyperthyroidism), but that a slightly abnormal TSH (<20 milli-int. units/L) plus a normal FF4 result, or the reverse, in a patient with no evident thyroid disease, constituted a false-positive result (worst-case scenario). We found a high diagnostic sensitivity, a relatively poor specificity, and a very low positive predictive value, approximately as low as 35% for both hypo-and hyperthyroidism.
The latter two can be vastly improved, with only minor sacrifices in sensitivity, if one uses for hospitalized patients TSH values of 0.05 and 12 milli-int. units/L as cutoff points (Figure 6, shaded areas) , instead of the reference interval designated for clinic patients (0.4-6.2). However, we emphasize that a wider reference interval would probably not be indicated if TSH were to be used as a single initial screening test in the hospital setting.
As illustrated by our cumulative data in Figure 6 , abnormal TSH values associated with NTI were clustered just above and below the normal reference interval. On the low side, they were typically (although not exclusively) still measurable, rather than undetectable (above 0.05 milli-int. Estimates are basedon finalpatientclassification and dataongroups3-5.
unit/L); and on the high side, they ranged predominantly from 6.2 to 12 milli-int. unitafL. Our findings in heart-transplant recipients confirm previous data of Wehmann et al. (12) on bone-marrow recipients. We, however, observed a higher prevalence of abnormal TSH values in our cross-section of hospitalized patients undergoing routine thyroid-ftmction testing (group 3) than has been reported recently by two other groups (2, 20) . This discrepancy could be explained by differences in the analytical performance of the sensitive TSH assays used, but much more probably by differences in patient selection, in the nature and severity of the systemic illnesses, and (or) in the timing of the tests. For example, we measured TSH when routine thyroid-function tests were ordered, quite often when a patient's status got worse. In the other reports (2, 20), all patients admitted to the hospital were screened on admission. From our longitudinal studies we would predict that some of the NTI-related abnormalities can be avoided if tests were performed exclusively on admission, i.e., before surgical procedures and before administration of drugs that are known to affect thyroid function.
The unexpected finding of an increased TSH preoperatively in patients with end-stage cardiac failure (group 1) remains unexplained. It might have been due to repeated administration of iodine-containing contrast agents for angiography. Klee and Hay (2) also found five patients with cardiopulmonary failure with TSH values ranging from 11.8 to 52.4 milli-int. unitsfL, but who had no obvious thyroid disease.
In conclusion, sensitive TSH measurements during NTI were found to be of clinical value in the diagnosis of hyperthyroidism.
TSH identified borderline cases and allowed a more definitive biochemical assessment than could be made solely on the basis of increased thyroid-hormone 
